Flatiron Health's Approach to Cancer Research
Under Carolyn Starrett's leadership, Flatiron Health is making significant strides in cancer research using machine learning and real world data. Their work involves not just curating vast amounts of data but also generating valuable insights that inform new therapies and decision-making in drug development. Starrett's unique perspective, shaped by her years at Flatiron and its journey from a private entity to an independent subsidiary of Roche, offers a nuanced understanding of the healthcare and pharmaceutical landscape.
International Expansion and Its Impact
Starrett highlights Flatiron Health's international expansion, focusing on patient populations in the UK, Germany, and Japan. This global approach allows the company to glean insights from diverse patient experiences and contribute to the broader field of cancer research. The partnership with the NHS Trust in Leeds is a notable step in bringing together a range of experts to turn patient experiences into actionable data and evidence.
Challenges and Opportunities in Building a Global Team
Building an international team presents unique challenges, from navigating different healthcare systems to integrating various cultures and work ethics. Starrett emphasizes the importance of local understanding and expertise in each market to tailor their approach effectively. This strategy enables Flatiron Health to resonate with and meet the needs of diverse patient populations and healthcare systems.
Expanding into Real World Evidence Services
Flatiron Health is moving beyond data curation to actively shaping how real world evidence is used in drug development. Starrett is excited about collaborations like the one with Sanofi, aiming to streamline clinical trials and make the drug development process more efficient. This approach is expected to accelerate the availability of new treatments and improve patient outcomes.
Future Prospects and Advice for New Leaders in Healthcare
Looking ahead, Starrett is enthusiastic about the potential breakthroughs in clinical trial processes and patient care improvements. Her advice to new entrepreneurs and leaders in healthcare is to stay focused, collaborate effectively, and be prepared for the long haul, as transformation in this sector requires persistence and a clear vision.
WORD FROM OUR SPONSORS:
Our sponsors for this episode are Sage Growth Partners and Quantum Health
Sage Growth Partners accelerates commercial success for healthcare organizations through a singular focus on growth. The company helps its clients thrive amid the complexities of a rapidly changing marketplace with deep domain expertise and an integrated application of research, strategy, and marketing. For more information, please go to www.sage-growth.com & follow Sage Growth Partners on social media - @sagegrowthpartners
Quantum Health is an award-winning consumer healthcare navigation company that delivers an unparalleled consumer experience based on empathy and trust, enabling employers to achieve industry-leading satisfaction rates and independently validated claim savings. Launched in 1999, Quantum Health’s model is based on years of consumer research and the insights learned from guiding millions of consumers and their providers through their healthcare journey. Visit: https://quantum-health.com/ and follow Quantum health on social media - @Quantum Health
Finally, to learn more about our guest and their company please use the links below:
- Guest's LinkedIn - Company LinkedIn - Website -
Also, be sure to follow Slice of Healthcare on our social channels:
- Website - LinkedIn - Twitter - YouTube - Newsletter -
